Boston Scientific Units

Penumbra, Boston Scientific

Boston Scientific to buy Penumbra for more than $14 billion

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots from veins and arteries.

· 1d · on MSN

Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots

· 1d · on MSN

Boston Scientific to buy Penumbra for $15 billion in cash, stock

· 1d

Boston Scientific announces agreement to acquire Penumbra, Inc.

· 1d

Boston Scientific to buy Penumbra in $14.5 billion deal

· 1d

Boston Scientific to acquire Penumbra for enterprise value of ~$14.5B

Reuters

Boston Scientific raises full-year profit forecast on heart devices unit strength

April 24 (Reuters) - Boston Scientific (BSX.N), opens new tab raised its annual profit forecast and beat Wall Street expectations for first-quarter results on the back of resilient demand for the company's heart devices, sending the medical device maker's ...

Seeking Alpha

Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost

Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected sales from its cardiology unit. As the company’s ...